NOMINATION AND STANDSTILL AGREEMENTNomination and Standstill Agreement • April 1st, 2015 • Aegerion Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This NOMINATION AND STANDSTILL AGREEMENT (the “Agreement”) is made as of March 29, 2015 by and among AEGERION Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), and the entities listed on Schedule A hereto (collectively, the “Sarissa Group”). In consideration of the covenants and promises set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:
